JNJ · Johnson & Johnson
232.55
EURUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Euro560.00B
PE
18.10
EV/EBITDA
15.2
DIV Yield
2.6%
Payout Ratio
47%
MQV Rating
5Very Weak
As at 21/08/2026 12:00:00 AM
Price Chart
Description
- All-Companies
Key Fundamentals
EPS 3 yr Growth
51.70%
EBITDA Margin
35.70%
Operating Cashflow
€21,735m
Free Cash Flow Return
21.30%
ROIC
23.30%
Interest Coverage
22.60
Quick Ratio
0.80
Performance
52 weeks range
Low 147.76 - 239.95
Trade Value (12mth)
US$4,763.00
1 week
3.1%
1 month
5.91%
YTD
32.55%
1 year
70.36%
All time high
239.95
Additional Data
Shares Outstanding (Fully Diluted)
2,440m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
25-Aug-26
Next Dividend Pay Date
08-Sep-26
Reporting Currency
EUR
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
Key Stakeholders
| Name | Title |
| Wellcome Trust Ltd. (Direct Investments) | Operating Division |
| Joaquin Duato | Individual |
| Employees Provident Fund | Pension Fund |
| Mill Creek Capital Advisors LLC | Subsidiary |
| Jennifer L. Taubert | Individual |
